Jillian A. Hung

The University of Melbourne — Australia

Medicine · Health Sciences

35h-index18.7kcitations95works11.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(42), Cancer Genomics and Diagnostics(35), PARP inhibition in cancer therapy(11), Cancer-related molecular mechanisms research(9), Genetic factors in colorectal cancer(9)

Publications44 total

Precise template-free correction restores gene function in Tay-Sachs disease while reframing is ineffective
Molecular Therapy — Nucleic Acids·2024· 3 citedOpen Access
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
Molecular Cancer·2024· 23 citedOpen Access
Timing of whole genome duplication is associated with tumor-specific MHC-II depletion in serous ovarian cancer
Nature Communications·2024· 13 citedOpen Access
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease
npj Genomic Medicine·2024· 5 citedOpen Access
Small-scale mutations are infrequent as mechanisms of resistance in post-PARP inhibitor tumour samples in high grade serous ovarian cancer
Scientific Reports·2023· 5 citedOpen Access
Table S4 from Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
2023Open Access
Supplementary Data from Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
2023Open Access
Table S1 from Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
2023Open Access
Supplementary Tables 1-7 from Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i>-Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic Driver
2023Open Access
Supplementary Methods, Figures 1-5 from Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i>-Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic Driver
2023Open Access
Supplementary Methods, Figures 1-5 from Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i>-Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic Driver
2023Open Access
Supplementary Data from Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
2023Open Access
Data from Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
2023Open Access
Supplementary Tables 1-7 from Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i>-Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic Driver
2023Open Access
Data from Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
2023Open Access
Data from Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
2023Open Access
Data from Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i>-Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic Driver
2023Open Access
Table S5 from Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
2023Open Access
Supplementary Data from Homologous Recombination DNA Repair Pathway Disruption and Retinoblastoma Protein Loss Are Associated with Exceptional Survival in High-Grade Serous Ovarian Cancer
2023Open Access
Data from Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Sián Fereday(44), David D.L. Bowtell(42), Anna DeFazio(40), Paul R. Harnett(31), Catherine J. Kennedy(28), Dariush Etemadmoghadam(27), Joshy George(27), Yoke-Eng Chiew(27), Alison H. Brand(24), Raghwa Sharma(23), Kathryn Alsop(21), Catherine Emmanuel(21), Alexander Dobrovic(21), Michael Friedländer(20), Nadia Traficante(20), Joy Hendley(20), Laura Galletta(16), Elizabeth L. Christie(15), Dale W. Garsed(15), Orla McNally(15)